ストックスクリーナーアプリを入手
0.4607
15.46%
0.0617
前日終値:
$0.399
開ける：
$0.372
24時間の取引高:
7.25M
Relative Volume:
1.99
時価総額：
$8.28M
収益：
$10.34M
当期純損益:
$-3.09M
株価収益率:
-1.6875
EPS:
-0.273
ネットキャッシュフロー:
$-736.20K
1週間 パフォーマンス:
+72.35%
1か月 パフォーマンス:
+50.11%
6か月 パフォーマンス:
-2.54%
1年 パフォーマンス:
+0.00%
1日の値動き範囲:
$0.372
$0.525
1週間の範囲:
$0.26
$0.84
52週間の値動き範囲:
$0.2105
$3.39
Bionexus Gene Lab Corp Stock (BGLC) Company Profile
名前
Bionexus Gene Lab Corp
電話
1-307-241-6898
住所
10-2 TOWER B, VERTICAL BUSINESS SUITE,, KUALA LUMPUR
BGLC を他の銘柄と比較する
| 株式 | 価格 | 時価総額 | 収益 | 当期純利益 | 現金流量 | EPS |
|---|---|---|---|---|---|---|
BGLC
BioNexus Gene Lab Corp Common stock
|
1.14 | 201.51M | 0 | 0 | 0 | 0.00 |
|
PSNYW
Polestar Automotive Holding Uk
|
0.29 | 612.00M | 2.07B | -1.42B | -1.37B | -0.6765 |
|
GOODO
Gladstone Commercial Corporation
|
20.65 | 372.90M | 0 | 0 | 0 | 0.00 |
|
MOBBW
Mobilicom Limited Warrants
|
0.82 | 278.60M | 0 | 0 | 0 | 0.00 |
|
SHMD
Schmid Group N V
|
3.01 | 129.62M | 0 | 0 | 0 | 0.00 |
|
JUNE
Dhandho Junoon Etf
|
3.65 | 47.48M | 0 | 0 | 0 | 0.00 |
Bionexus Gene Lab Corp (BGLC) 最新ニュース
IQVIA Holdings Inc. (NYSE:IQV) Receives $255.82 Consensus PT from Analysts - Defense World
BioNexus Gene Lab Receives Temporary Exception from Nasdaq Bid Price RuleOn December 27, 2024, BioNexus Gene Lab Corp. (NASDAQ:BGLC) announced in a recent 8-K filing that it has been granted a temporary exception by the Nasdaq Hearings Pa - Defense World
Silence Therapeutics Transitioning to U.S. Domestic Issuer Status - Defense World
Stock market news: Neumora Therapeutics down by 80.75% while N2OFF surged by 333.47% during mid day trading - Business Upturn
Short Interest in ABVC BioPharma, Inc. (NASDAQ:ABVC) Rises By 148.2% - Defense World
BioNexus Gene Lab Corp. (NASDAQ:BGLC) Short Interest Update - Defense World
BioNexus Gene Lab stock hits 52-week low at $0.22 - Investing.com
Critical Survey: BioNexus Gene Lab (NASDAQ:BGLC) versus MDxHealth (NASDAQ:MDXH) - Defense World
BioNexus Gene Lab Leads Our Top 3 US Penny Stocks - Simply Wall St
Stock market news: Senti Biosciences surge by 428.24% while Mondee Holdings plunged by 46.49% during mid day trading - Business Upturn
Thinking about buying stock in BioNexus Gene Lab, Gladstone Inve - GuruFocus.com
BGLC stock touches 52-week low at $0.28 amid sharp annual decline By Investing.com - Investing.com South Africa
BGLC stock touches 52-week low at $0.28 amid sharp annual decline - Investing.com Nigeria
BioNexus Gene Lab Corp. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2024 - Marketscreener.com
BioNexus Gene Lab Corp (BGLC) Quarterly 10-Q Report - Quartzy
BioNexus Gene Lab stock hits 52-week low at $0.32 By Investing.com - Investing.com Canada
BioNexus Gene Lab stock hits 52-week low at $0.32 - Investing.com
BioNexus Gene Lab faces Nasdaq delisting over price rule - Investing.com India
BioNexus Gene Lab faces Nasdaq delisting over price rule By Investing.com - Investing.com Nigeria
BioNexus Gene Lab Faces Delisting and Leadership Changes - TipRanks
BioNexus Gene Lab announces board resignations By Investing.com - Investing.com Australia
BioNexus Gene Lab announces board resignations - Investing.com India
BioNexus Gene Lab faces vote impact from alleged proxy issues By Investing.com - Investing.com Australia
BioNexus Gene Lab faces vote impact from alleged proxy issues - Investing.com India
bionexus gene lab corp Earnings dates - RTTNews
BioNexus Gene Lab Corporation announces entry into Biogas - GlobeNewswire
BioNexus Gene Lab Corporation announces entry into Biogas Sector via Teaming Agreement with Protech Builders Sdn. Bhd. - StockTitan
BioNexus Gene Lab Corp (BGLC) Stock: A Year of Market Fluctuations - The InvestChronicle
There is no way BioNexus Gene Lab Corp (BGLC) can keep these numbers up - SETE News
In the Green: BioNexus Gene Lab Corp (BGLC) Closes at 0.39, Up/Down 8.36 from Previous Day - The Dwinnex
BioNexus partners with Vitarray for gene detection - Investing.com
BioNexus Gene Lab Corp. Signs Strategic Outsourcing Agreement with VITARRAY Global Pte. Ltd. - Marketscreener.com
BioNexus Gene Lab Corp (BGLC) requires closer examination - US Post News
Bionexus Gene Lab in MOU with Shenzhen Rongguang Group for cancer screening - TipRanks
BioNexus Gene Lab Corp. Signs Strategic Partnership MOU with Shenzhen Rongguang Group to Advance Cancer Screening, Precision Medicine, and Preventative Healthcare Solutions - GlobeNewswire
Closing Figures: BioNexus Gene Lab Corp (BGLC)’s Positive Finish at 0.36, Up 2.48 - The Dwinnex
BioNexus Gene Lab Corp (BGLC) Stock: 52-Week Performance Insights and Trading Volume - The InvestChronicle
BioNexus subsidiary invests in color paste production By Investing.com - Investing.com India
Bionexus Gene Lab’s Chemrex invests RM 2M to begin color paste production - TipRanks
BioNexus Gene Lab Corp Announces New Business Developments for Subsidiary Chemrex with Investment in High-Quality Color Paste Production - StockTitan
BioNexus Gene Lab Corp revises stockholder quorum requirement - Investing.com India
How did BioNexus Gene Lab Corp (BGLC) fare last session? - US Post News
An analyst sees good growth prospects for BioNexus Gene Lab Corp (BGLC) - SETE News
BioNexus Receives Government Backing for Healthcare Tech - TipRanks
BioNexus and MyCIF invest in Malaysian healthcare tech By Investing.com - Investing.com Australia
BioNexus Gene Lab Corp. Announces Successful Securities Commission of Malaysia (MyCIF) Co-Investment in Ascension Innovation Sdn Bhd - Yahoo Finance UK
Bionexus Gene Lab Corp (BGLC) 財務データ
収益
当期純利益
現金流量
EPS
0.13%
1.30%
大文字化:
|
ボリューム (24 時間):